NCR1 and melanoma: The presence of NKp46+ NK cells infiltrating primary melanoma, the reduced expression of NKp46 by NK cells in certain stage IV patients and its likely correlation with the duration of stage IV are new arguments for the importance of this receptor in the innate immune response against melanoma.